Hardy Reed’s Medpace MEDP Stock Holding History

Hardy Reed’s Portfolio MEDP Stock Details MEDP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$396K	Buy	635 +3	+0.5%	+$1.76K	0.03%	186
2026 Q2	$335K	Hold	632	–	–	0.02%	189
2026 Q1	$303K	Sell	632 -4	-0.6%	-$2.05K	0.02%	188
2025 Q4	$357K	Buy	636 +4	+0.6%	+$2.27K	0.03%	179
2025 Q3	$325K	Sell	632 -105	-14%	-$45.8K	0.02%	187
2025 Q2	$231K	Hold	737	–	–	0.02%	223
2025 Q1	$225K	Hold	737	–	–	0.02%	217
2024 Q4	$245K	Hold	737	–	–	0.02%	215
2024 Q3	$246K	Hold	737	–	–	0.02%	216
2024 Q2	$304K	Sell	737 -130	-15%	-$51.5K	0.03%	181
2024 Q1	$350K	Sell	867 -166	-16%	-$58.4K	0.04%	82
2023 Q4	$317K	Sell	1,033 -5	-0.5%	-$1.35K	0.04%	90
2023 Q3	$251K	Hold	1,038	–	–	0.05%	85
2023 Q2	$249K	Buy	+1,038	New	+$216K	0.04%	82

Other funds holding MEDP

Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return

Wasatch Advisors Salt Lake City, Utah $13.5B AUM 16.58% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $106B AUM 2.29% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $551B AUM 33.95% 1-Year Est. Return

Bessemer Group Woodbridge, New Jersey $72.8B AUM 32.97% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.32T AUM 44.66% 1-Year Est. Return

Thrivent Financial for Lutherans Minneapolis, Minnesota $61B AUM 26.91% 1-Year Est. Return

Citigroup New York $308B AUM 40.94% 1-Year Est. Return

Stephens Investment Management Group Houston, Texas $9.29B AUM 41.16% 1-Year Est. Return

GW&K Investment Management Boston, Massachusetts $11.8B AUM 29.45% 1-Year Est. Return

Hardy Reed's MEDP Position: Q3 2026 in Review

Hardy Reed increased its Medpace (MEDP) stake by 0.47% in Q3 2026, buying an estimated $1.76K and bringing the position to 635 shares worth $396K. The position accounts for 0.03% of the portfolio, ranked #186.

Hardy Reed first reported a position in MEDP in Q2 2023 and has held it in 14 quarters since. 438 funds tracked by Wall St. Rank hold MEDP as of Q3 2026.

Hardy Reed held 635 shares of Medpace worth $396K as of Q3 2026.
Hardy Reed bought 3 Medpace shares in Q3 2026, an estimated $1.76K.
Medpace made up 0.03% of Hardy Reed's portfolio in Q3 2026, its #186 holding.
Hardy Reed first reported a position in Medpace in Q2 2023 and has held it in 14 quarters since.
438 funds tracked by Wall St. Rank held Medpace as of Q3 2026.

Based on Hardy Reed's 13F filing for Q3 2026, filed 6 Nov 2026.